Characterisation and immunosuppressive activity of human cartilage-derived mesenchymal stem cells

Cytotechnology

Volumn 70, Issue 3, 2018, Pages 1037-1050

  Sandrasaigaran, Pratheep ^a,b   Algraittee, Satar Jabbar Rahi ^a,c   Ahmad, Azfar Rizal ^d   Vidyadaran, Sharmili ^a   Ramasamy, Rajesh ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Malaysia   (India)

^c UNIVERSITY OF KERBALA   (Iraq)

^d Department of Orthopaedics   (Malaysia)

Author keywords

Cartilage; Cell cycle; Cell differentiation; Mesenchymal; Sports injuries

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR REX1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTHROSCOPY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHONDROCYTE; COCULTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREGULATION; MESENCHYMAL STEM CELL; OSTEOCYTE; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; SPORT INJURY; T LYMPHOCYTE ACTIVATION;

EID: 85045069689     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-017-0182-4     Document Type: Article

References (41)

1. Alsalameh S, Amin R, Gemba T, Lotz M (2004) Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheumatol 50:1522–1532. 10.1002/art.20269
2. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655
3. Cho KJ, Trzaska KA, Greco SJ, McArdle J, Wang FS, Ye JH, Rameshwar P (2005) Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23:383–391. 10.1634/stemcells.2004-0251
4. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Uccelli A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367–372. 10.1182/blood-2005-07-2657
5. Csaki C, Schneider PR, Shakibaei M (2008) Mesenchymal stem cells as a potential pool for cartilage tissue engineering. Ann Anat 190:395–412. 10.1016/j.aanat.2008.07.007
6. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I (2006) The role of mesenchymal stem cells in haemopoiesis. Blood Rev 20:161–171. 10.1016/j.blre.2005.11.002
7. De Bari C, Dell’Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheumatol 44:1928–1942
8. Detterline AJ, Goldberg S, Bach BR Jr, Cole BJ (2005) Treatment options for articular cartilage defects of the knee. Orthop Nurs 24:361–366 (quiz 367–368)
9. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317
10. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827–1835
11. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA (2008a) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26:795–797. 10.1038/nbt1418
12. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Melton DA (2008b) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269–1275. 10.1038/nbt.1502
13. Javazon EH, Beggs KJ, Flake AW (2004) Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414–425. 10.1016/j.exphem.2004.02.004
14. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, McGonagle D (2002) Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheumatol 46:3349–3360. 10.1002/art.10696
15. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, McGonagle D (2008) Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheumatol 58:1731–1740
16. Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthr Res Ther 9:204. 10.1186/ar2116
17. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Tada T (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25:2475–2485. 10.1128/MCB.25.6.2475-2485.2005
18. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441. 10.1016/S0140-6736(04)16104-7
19. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ringden O (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733–1738. 10.1038/sj.leu.2404777
20. Lee SY, Nakagawa T, Reddi AH (2009) Mesenchymal progenitor cells derived from synovium and infrapatellar fat pad as a source for superficial zone cartilage tissue engineering: analysis of superficial zone protein/lubricin expression. Tissue Eng Part A 16:317–325
21. Otto W, Rao J (2004) Tomorrow’s skeleton staff: mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 37:97–110
22. Palermo AT, LaBarge MA, Doyonnas R, Pomerantz J, Blau HM (2005) Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol 279:336–344
23. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Zhou C (2008) Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem cells Dev 17:761–774. 10.1089/scd.2007.0217
24. Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271–278. 10.1634/stemcells.19-4-271
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
26. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783–791
27. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G, Dazzi F (2007a) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71–76. 10.1097/01.tp.0000244572.24780.54
28. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F (2007b) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21:304–310. 10.1038/sj.leu.2404489
29. Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F (2008) The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 251:131–136. 10.1016/j.cellimm.2008.04.009
30. Rasmusson I, Uhlin M, Le Blanc K, Levitsky V (2007) Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 82:887–893. 10.1189/jlb.0307140
31. Rogers MB, Hosler BA, Gudas LJ (1991) Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113:815–824
32. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005) Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheumatol 52:2521–2529
33. Su W, Zhang H, Jia Z, Zhou C, Wei Y, Hu S (2006) Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium? Stem Cells 24:349–356
34. Tabera S, Perez-Simon JA, Diez-Campelo M, Sanchez-Abarca LI, Blanco B, Lopez A, San Miguel JF (2008) The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93:1301–1309. 10.3324/haematol.12857
35. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. 10.1016/j.cell.2006.07.024
36. Tokcaer-Keskin Z, Akar AR, Ayaloglu-Butun F, Terzioglu-Kara E, Durdu S, Ozyurda U, Akcali KC (2009) Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies. Can J Physiol Pharmacol 87:143–150. 10.1139/Y08-111
37. Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, Feldmann M (2007) Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthr Res Ther 9:301. 10.1186/ar2103
38. Vellasamy S, Tong CK, Azhar NA, Kodiappan R, Chan SC, Veerakumarasivam A, Ramasamy R (2016) Human mesenchymal stromal cells modulate T-cell immune response via transcriptomic regulation. Cytotherapy 18:1270–1283
39. Wu R, Gu B, Zhao X, Tan Z, Chen L, Zhu J, Zhang M (2013) Derivation of multipotent nestin(+)/CD271 (-)/STRO-1 (-) mesenchymal-like precursors from human embryonic stem cells in chemically defined conditions. Hum Cell 26:19–27. 10.1007/s13577-011-0022-3
40. Yamanaka S (2008) Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif 41:51–56. 10.1111/j.1365-2184.2008.00493.x
41. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920. 10.1126/science.1151526